• 1.中國(guó)醫(yī)學(xué)科學(xué)院 北京協(xié)和醫(yī)院基本外科（北京100730）;;
  • 2.中國(guó)醫(yī)學(xué)科學(xué)院 北京協(xié)和醫(yī)院消化內(nèi)科;

目的 　研究乙酰肝素酶（HPA1）在結(jié)直腸癌中的表達(dá)，探討其與腫瘤生長(zhǎng)和預(yù)后的關(guān)系。
方法 　采用RT-PCR和免疫組織化學(xué)技術(shù)，從mRNA和蛋白水平對(duì)HPA1在結(jié)直腸癌及其周圍組織中的表達(dá)進(jìn)行定性和定位研究，初步分析其與結(jié)直腸癌臨床病理特征和臨床預(yù)后的關(guān)系。
結(jié)果 　HPA1 mRNA在結(jié)直腸癌組織中的表達(dá)明顯高于周圍正常組織，HPA1 mRNA在正常腸道組織中的表達(dá)與是否患結(jié)直腸腺瘤呈正相關(guān)（r=0.352，P=0.024）； 免疫組化結(jié)果發(fā)現(xiàn)，HPA1蛋白主要表達(dá)在結(jié)直腸癌組織、腫瘤邊緣的浸潤(rùn)組織和血管內(nèi)皮細(xì)胞； HPA1陰性患者的2年無(wú)病生存率（88.9%）高于HPA1陽(yáng)性患者（50.0%），但差異無(wú)統(tǒng)計(jì)學(xué)意義（P=0.078）。
結(jié)論 　HPA1在結(jié)直腸癌組織中呈高表達(dá)，與腫瘤的發(fā)生和預(yù)后有一定的關(guān)系。

引用本文： 肖毅,馮云路,錢家鳴,陳原稼,林國(guó)樂,張?jiān)聦?吳斌,邱輝忠. 乙酰肝素酶在結(jié)直腸癌中的表達(dá)及意義. 中國(guó)普外基礎(chǔ)與臨床雜志, 2007, 14(4): 442-447. doi: 復(fù)制

版權(quán)信息： ?四川大學(xué)華西醫(yī)院華西期刊社《中國(guó)普外基礎(chǔ)與臨床雜志》版權(quán)所有，未經(jīng)授權(quán)不得轉(zhuǎn)載、改編

1. 　Bernfield M, Gotte M, Park PW, et al. Functions of cell surface heparan sulfate proteoglycans [Ｊ]　. Annu Rev Biochem, 1999; 68∶729.
2. 　Sanderson RD. Heparan sulfate proteoglycans in invasion and metastasis [Ｊ]　. Semin Cell Dev Biol, 2001; 12(2)∶89.
3. 　Kleeff J, Ishiwata T, Kumbasar A, et al. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer [Ｊ]　. J Clin Invest, 1998; 102(9)∶1662.
4. 　Elkin M, Ilan N, Ishai-Michaeli R, et al. Heparanase as mediator of angiogenesis: mode of action [Ｊ]　. FASEB J, 2001; 15(9)∶1661　.
5. 　Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual [M]　. 6th Edition. New York: Springer, 2002　∶113-119　.
6. 　Vlodavsky I, Friedmann Y, Elkin M, et al. Mammalian hepa-ranase: gene cloning, expression and function in tumor progression and metastasis [Ｊ]　. Nat Med, 1999; 5(7)∶793.
7. 　Koliopanos A, Friess H, Kleeff J, et al. Heparanase expression in primary and metastatic pancreatic cancer [Ｊ]　. Cancer Res, 2001; 61(12)∶4655.
8. 　Takaoka M, Naomoto Y, Ohkawa T, et al. Heparanase expression correlates with invasion and poor prognosis in gastric cancers [Ｊ]　. Lab Invest, 2003; 83(5)∶613.
9. 　Xiao Y, Kleeff J, Shi X, et al. Heparanase expression in hepatocellular carcinoma and the cirrhotic liver [Ｊ]　. Hepatol Res, 2003; 26(3)∶192.
10. 　Stadlmann S, Moser PL, Pollheimer J, et al. Heparanase-1 gene expression in normal, hyperplastic and neoplastic prostatic tissue [Ｊ]　. Eur J Cancer, 2003; 39(15)∶2229.
11. 　Hulett MD, Freeman C, Hamdorf BJ, et al. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis [Ｊ]　. Nat Med, 1999; 5(7)∶803.
12. 　Nobuhisa T, Naomoto Y, Ohkawa T, et al. Heparanase expression correlates with malignant potential in human colon cancer [Ｊ]　. J Cancer Res Clin Oncol, 2005; 131(4)∶229.
13. 　Friedmann Y, Vlodavsky I, Aingorn H, et al. Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis [Ｊ]　. Am J Pathol, 2000; 157(4)∶1167.
14. 　Edovitsky E, Elkin M, Zcharia E, et al. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis [Ｊ]　. J Natl Cancer Inst， 2004; 96(16)∶1219.
15. 　Sato T, Yamaguchi A, Goi T, et al. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis [Ｊ]　. J Surg Oncol, 2004; 87(4)∶174.
16. 　Wang ZN, Xu HM, Jiang L, et al. Positive association of Rh-oC gene overexpression with tumour invasion and lymphatic metastasis in gastric carcinoma [Ｊ]　. Chin Med J (Engl), 2005; 118(6)∶502.
  1. 1. 　Bernfield M, Gotte M, Park PW, et al. Functions of cell surface heparan sulfate proteoglycans [Ｊ]　. Annu Rev Biochem, 1999; 68∶729.
  2. 2. 　Sanderson RD. Heparan sulfate proteoglycans in invasion and metastasis [Ｊ]　. Semin Cell Dev Biol, 2001; 12(2)∶89.
  3. 3. 　Kleeff J, Ishiwata T, Kumbasar A, et al. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer [Ｊ]　. J Clin Invest, 1998; 102(9)∶1662.
  4. 4. 　Elkin M, Ilan N, Ishai-Michaeli R, et al. Heparanase as mediator of angiogenesis: mode of action [Ｊ]　. FASEB J, 2001; 15(9)∶1661　.
  5. 5. 　Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual [M]　. 6th Edition. New York: Springer, 2002　∶113-119　.
  6. 6. 　Vlodavsky I, Friedmann Y, Elkin M, et al. Mammalian hepa-ranase: gene cloning, expression and function in tumor progression and metastasis [Ｊ]　. Nat Med, 1999; 5(7)∶793.
  7. 7. 　Koliopanos A, Friess H, Kleeff J, et al. Heparanase expression in primary and metastatic pancreatic cancer [Ｊ]　. Cancer Res, 2001; 61(12)∶4655.
  8. 8. 　Takaoka M, Naomoto Y, Ohkawa T, et al. Heparanase expression correlates with invasion and poor prognosis in gastric cancers [Ｊ]　. Lab Invest, 2003; 83(5)∶613.
  9. 9. 　Xiao Y, Kleeff J, Shi X, et al. Heparanase expression in hepatocellular carcinoma and the cirrhotic liver [Ｊ]　. Hepatol Res, 2003; 26(3)∶192.
  10. 10. 　Stadlmann S, Moser PL, Pollheimer J, et al. Heparanase-1 gene expression in normal, hyperplastic and neoplastic prostatic tissue [Ｊ]　. Eur J Cancer, 2003; 39(15)∶2229.
  11. 11. 　Hulett MD, Freeman C, Hamdorf BJ, et al. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis [Ｊ]　. Nat Med, 1999; 5(7)∶803.
  12. 12. 　Nobuhisa T, Naomoto Y, Ohkawa T, et al. Heparanase expression correlates with malignant potential in human colon cancer [Ｊ]　. J Cancer Res Clin Oncol, 2005; 131(4)∶229.
  13. 13. 　Friedmann Y, Vlodavsky I, Aingorn H, et al. Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis [Ｊ]　. Am J Pathol, 2000; 157(4)∶1167.
  14. 14. 　Edovitsky E, Elkin M, Zcharia E, et al. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis [Ｊ]　. J Natl Cancer Inst， 2004; 96(16)∶1219.
  15. 15. 　Sato T, Yamaguchi A, Goi T, et al. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis [Ｊ]　. J Surg Oncol, 2004; 87(4)∶174.
  16. 16. 　Wang ZN, Xu HM, Jiang L, et al. Positive association of Rh-oC gene overexpression with tumour invasion and lymphatic metastasis in gastric carcinoma [Ｊ]　. Chin Med J (Engl), 2005; 118(6)∶502.